ALB and autoimmune hepatitis: Our novel finding, presented via the competing risk analysis, shows that AIH carries a similar risk of waitlist removal due to death or deterioration compared to PBC and higher risk compared to PSC after accounting for factors such as age, sex, listing MELD, listing albumin, UNOS region, and blood type.